Internal Medicine, Gastroenterology · Missoula, MT
NPI
1669511606
Since 2007
Specialty
Internal Medicine, Gastroenterology
Code 207RG0100X
Group practices
2
Medicare group memberships
Hospitals
4
Hospital affiliations
1930 W Broadway St Ste A
Missoula, MT, 59808
Phone (406) 541-6844
Groups this clinician bills Medicare through
Medicare paid, 2024
$241K
7,281 services
Medicare patients, 2024
722
Average age 73
Drug cost, 2024
$446K
854 prescriptions
Company payments, 2025
$236
From 9 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Casey J Kolendich was code 45380 (lower gi endoscopy - other), 291 times for 285 patients. In total Casey J Kolendich billed 7,281 services in 47 codes, and Medicare paid $241K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2024-10-07.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 45380 Lower GI Endoscopy - Other | Facility | 291 | 285 | $87.49 | $25K |
| 45385 Colonoscopy - Lesion Removal | Facility | 232 | 227 | $202.56 | $47K |
| 43239 Upper GI Endoscopy | Facility | 130 | 124 | $76.87 | $9,993 |
| G0105 Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 83 | 83 | $173.83 | $14K |
| 99214 Office E&M - Established | Office | 71 | 56 | $91.02 | $6,462 |
| 43235 Upper GI Endoscopy | Facility | 49 | 47 | $77.45 | $3,795 |
| 99231 Hospital E&M - Subsequent | Facility | 42 | 32 | $38.23 | $1,606 |
| 99215 Office E&M - Established | Office | 35 | 31 | $136.83 | $4,789 |
| G0121 Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | Facility | 33 | 33 | $174.41 | $5,756 |
| 99213 Office E&M - Established | Office | 21 | 21 | $60.91 | $1,279 |
| 99232 Hospital E&M - Subsequent | Facility | 20 | 16 | $60.95 | $1,219 |
| 99223 Hospital E&M - Initial | Facility | 19 | 19 | $133.77 | $2,542 |
| 43249 Upper GI Endoscopy | Facility | 17 | 14 | $104.42 | $1,775 |
| 45378 Lower GI Endoscopy - Other | Facility | 14 | 14 | $123.53 | $1,729 |
By year: 2022 $149K for 2,801 services; 2023 $240K for 6,611 services; 2024 $241K for 7,281 services.
Lab tests billed to Medicare, 2023
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 88305 Surgical Pathology Examination | 139 | 64 | $27.59 | $3,835 |
Medicare prescription drug claims, 2024
In 2024, the drug Casey J Kolendich prescribed most often to Medicare patients was Peg 3350-Electrolyte (Sodium Chloride/Nahco3/Kcl/Peg), with 480 prescriptions and refills. In total Casey J Kolendich wrote 854 Medicare prescriptions that cost $446K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Peg 3350-Electrolyte Sodium Chloride/Nahco3/Kcl/Peg | 480 | 480 | 458 | $12K |
| Omeprazole Generic | 113 | 231 | 45 | $1,052 |
| Gavilyte-N Sodium Chloride/Nahco3/Kcl/Peg | 58 | 58 | 56 | $1,136 |
| Sutab Sod Sulf/Pot Chloride/Mag Sulf | 27 | 27 | 27 | $4,315 |
| Humira(Cf) Pen Adalimumab | 21 | 25 | Under 11 | $163K |
| Mesalamine Generic | 19 | 48 | Under 11 | $28K |
| Mesalamine Er Mesalamine | 17 | 17 | Under 11 | $2,430 |
| Lansoprazole Generic | 14 | 16 | Under 11 | $387 |
| Azathioprine Generic | 13 | 29 | Under 11 | $951 |
| Gavilyte-G Peg3350/Sod Sulf,bicarb,cl/Kcl | 13 | 13 | 12 | $212 |
Brand drugs: 214 claims; generic drugs: 640 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Casey J Kolendich $236 ($236 in general payments such as food, travel and fees) from 9 companies. The largest payer was Janssen Biotech, Inc. with $87.8.
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. JNJ | 3 | $87.8 |
| Regeneron Healthcare Solutions, Inc. REGN | 1 | $23.74 |
| Madrigal Pharmaceuticals MDGL | 1 | $21.09 |
| Abbvie Inc. ABBV | 1 | $19.93 |
| Lilly USA, LLC LLY | 1 | $18.73 |
| Aimmune Therapeutics, Inc. | 1 | $17.95 |
| Orphalan Inc | 1 | $16.08 |
| Takeda Pharmaceuticals U.S.A., Inc. TAK | 1 | $15.74 |
| Celltrion USA Inc. 068270.KS | 1 | $15.38 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.